Get the Stockscreener App
9.77
0.81%
-0.08
Nyxoah Sa stock is traded at $9.77, with a volume of 112.29K.
It is down -0.81% in the last 24 hours and up +29.58% over the past month.
Nyxoah SA is a health-technology company focused on the development and commercialization of solutions and services to treat sleep disordered breathing conditions. Nyxoah's solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe Obstructive Sleep Apnea (OSA), the common sleep disordered breathing condition that is associated with increased mortality risk and comorbidities including cardiovascular diseases, depression and stroke.
See More
Previous Close:
$9.85
Open:
$9.46
24h Volume:
112.29K
Relative Volume:
1.36
Market Cap:
$365.66M
Revenue:
$4.71M
Net Income/Loss:
$-46.77M
P/E Ratio:
-5.8182
EPS:
-1.6792
Net Cash Flow:
$-60.34M
1W Performance:
+8.08%
1M Performance:
+29.58%
6M Performance:
+11.28%
1Y Performance:
+117.11%
1-Day Range:
$9.26
$9.8543
1-Week Range:
$8.78
$10.07
52-Week Range:
$4.00
$20.00
Nyxoah Sa Stock (NYXH) Company Profile
Name
Nyxoah Sa
Sector
Industry
Phone
-
Address
-
Compare NYXH with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NYXH
Nyxoah Sa
|
9.77 | 365.66M | 4.71M | -46.77M | -60.34M | -1.6792 |
|
ISRG
Intuitive Surgical Inc
|
544.02 | 193.77B | 7.87B | 2.24B | 586.00M | 6.22 |
|
BDX
Becton Dickinson Co
|
234.43 | 67.99B | 20.18B | 1.71B | 3.07B | 5.94 |
|
ALC
Alcon Inc
|
83.71 | 41.40B | 9.76B | 1.16B | 665.00M | 2.34 |
|
RMD
Resmed Inc
|
236.17 | 34.67B | 4.81B | 1.11B | 1.35B | 7.55 |
|
WST
West Pharmaceutical Services Inc
|
336.91 | 24.40B | 2.88B | 499.60M | 321.60M | 6.74 |
Nyxoah Sa Stock (NYXH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-31-23 | Initiated | H.C. Wainwright | Buy |
| Jul-19-23 | Initiated | Robert W. Baird | Neutral |
| Apr-21-22 | Initiated | Oppenheimer | Outperform |
| Apr-06-22 | Initiated | Wolfe Research | Peer Perform |
| Dec-21-21 | Resumed | Cantor Fitzgerald | Overweight |
| Jul-28-21 | Initiated | Cantor Fitzgerald | Overweight |
View All
Nyxoah Sa Stock (NYXH) Latest News
Retail investors are Nyxoah S.A.'s (EBR:NYXH) biggest owners and were rewarded after market cap rose by €38m last week - Simply Wall St
Nyxoah (NASDAQ:NYXH) Stock Price Up 1.2% – Here’s What Happened - Defense World
Nyxoah Receives Transparency Notification from BlackRock, Inc. - TipRanks
Nyxoah: The Future Of OSA (NASDAQ:NYXH) - Seeking Alpha
How the (NYXH) price action is used to our Advantage - Stock Traders Daily
Publication relating to transparency notifications - GlobeNewswire
BlackRock Takes 3% Stake in Medical Device Maker Nyxoah in Strategic Investment Move - StockTitan
Invitation to attend the special shareholders’ meeting of the Company to be held on December 19, 2024 - Finansavisen
(NYXH) Investment Analysis and Advice - Stock Traders Daily
Nyxoah's SWOT analysis: sleep apnea innovator faces growth hurdles - Investing.com
Nyxoah's SWOT analysis: sleep apnea innovator faces growth hurdles By Investing.com - Investing.com UK
Nyxoah's nerve stimulation device meets endpoints in sleep apnoea studyMedical Device Network - Oficjalny Portal Gminy Brzesko
HC Wainwright Reaffirms “Buy” Rating for Nyxoah (NASDAQ:NYXH) - Defense World
Nyxoah’s Genio Neurostimulator for OSA Launches in England - Sleep Review
Nyxoah's SWOT analysis: sleep apnea innovator's stock poised for US launch - Investing.com
Nyxoah Launches Revolutionary Sleep Apnea Treatment in England with First NHS-Covered Implants - StockTitan
Nyxoah Announces Commercial Launch of Genio® Innovative Therapy in England - GlobeNewswire
Nyxoah Announces Commercial Launch of Genio Innovative Therapy in England - Marketscreener.com
Where are the Opportunities in (NYXH) - Stock Traders Daily
Nyxoah Updates Share Capital and Voting Rights - TipRanks
Information on the Total Number of Voting Rights And Shares: Nyxoah - The Korea Bizwire
Information on the total number of voting rights and shares - GlobeNewswire
Objective long/short (NYXH) Report - Stock Traders Daily
Nyxoah (NASDAQ:NYXH) vs. Alpha Tau Medical (NASDAQ:DRTS) Head to Head Contrast - Defense World
Nyxoah to Participate in the Piper Sandler 36th Annual Healthcare Conference - The Korea Bizwire
Nyxoah to Present at Healthcare Conference Amidst Growth - TipRanks
Nyxoah to Present Sleep Apnea Innovation at Piper Sandler Healthcare Conference | NYXH Stock News - StockTitan
Nyxoah SA (NYXH) Reports Q3 Loss, Tops Revenue Estimates - MSN
Invitation to attend the special shareholders’ meeting of the Company to be held on December 19, 2024: Nyxoah - The Korea Bizwire
Nyxoah Schedules Special Meeting to Vote on EIB Loan Agreement Terms | NYXH Stock News - StockTitan
Publication Relating to Transparency Notifications: Nyxoah - The Korea Bizwire
Nyxoah’s Voting Rights Shift with ResMed Stake - TipRanks
ResMed's Stake in Nyxoah Drops Below 5% Threshold in Latest Holdings Update | NYXH Stock News - StockTitan
Publication relating to transparency notifications, Business Wires News - AsiaOne
Nyxoah S.A. (NASDAQ:NYXH) Short Interest Down 17.4% in October - MarketBeat
Nyxoah's SWOT analysis: sleep apnea device maker's stock poised for growth - Investing.com India
Nyxoah Third Quarter 2024 Earnings: €0.50 loss per share (vs €0.27 loss in 3Q 2023) - Simply Wall St
Nyxoah Reports Third Quarter Financial and Operating Results - Wahanariau
Nyxoah sales jump 30% to €1.3 million in Q3 2024 - Medical Buyer
Nyxoah SA Reports Growth Amid Clinical Advances - TipRanks
EQS-News: Nyxoah Reports Third Quarter Financial and Operating Results - sharewise
Nyxoah Eyes Strong US Launch Amid Financial Growth - TipRanks
Nyxoah S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Nyxoah Reports Third Quarter Financial and Operating Results, Business Wires News - AsiaOne
(NYXH) Investment Report - Stock Traders Daily
Nyxoah Q3 Revenue Surges 30% as FDA Approval Timeline Stays on Track for 2025 - StockTitan
Nyxoah SA (NYXH) Q3 2024: Everything You Need To Know Ahead Of Earnings - Yahoo Finance
Nyxoah SA Announces CFO Changes - Marketscreener.com
Nyxoah participates in a conference call with Cantor Fitzgerald - TipRanks
Nyxoah Appoints John Landry as Chief Financial Officer - The Manila Times
Nyxoah SA (NYXH) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release - MSN
Nyxoah Sa Stock (NYXH) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.03%
1.01%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):